Opposition in Kerala accuses Health department of palming off expired drugs to unsuspecting government hospital patients

Opposition leader V.D. Satheesan alleges politically sanctioned corruption in medical services corporation

Published - October 25, 2023 11:04 am IST - Thiruvananthapuram

Kerala Leader of the Opposition V.D. Satheesan

Kerala Leader of the Opposition V.D. Satheesan | Photo Credit: THULASI KAKKAT

The Congress-led United Democratic Front (UDF) has opened a new battlefront against the Left Democratic Front (LDF) government by accusing the Health department of imperilling public health by allegedly distributing medicines past their expiry date to commoners seeking medical care in public-funded hospitals.

Leaning on a Comptroller and Auditor General (CAG) report, Leader of the Opposition V.D. Satheesan on Tuesday alleged politically sanctioned big-ticket corruption in the Kerala Medical Services Corporation (KMSC) responsible for large-scale procurement of essential drugs. The agency violated norms by purchasing medicine approaching the lapse date to help pharmaceutical companies expend unused stocks in reciprocation for outsize backhanders.

He said that government rules mandated that the KMSC only purchase medicines with a minimum expiry period of three years. However, the KMSC violated the norms in the procurement of 1,610 batches of medicine. It distributed drugs that passed their validity date through at least 26 public hospitals, jeopardising the health of trusting patients.

Mr. Satheesan also alleged that the KMSC purchased drugs of dubious quality that drug inspectors had not cleared for sale for distribution through 483 government hospitals. Quoting the CAG report, Mr. Satheesan also alleged that the KSMC issued drugs prohibited for sale to patients through 148 government hospitals. A big pharma had found a conduit in the KSMC to channel expired and banned drugs to the unsuspecting public.

He said the modus operandi the KSMC used for corruption was simple. The companies sold the medicines to the KSMC at 10% to 20% of their market value.

“For one, the KSMC would pay the actual cost of the medicine to Big Pharma, which, in turn, would reroute 80% of the remittance to officials responsible for green-lighting the tender agreement as a bribe,” Mr. Satheesan said.

Mr. Satheesan said the wrongdoing flagged by the CAG was the tip of the iceberg. . He alleged that the KMSC had brazenly violated quality control norms at the cost of public health.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.